GlaxoSmithKline takes RSV maternal vaccine candidate into Phase 3 study

GlaxoSmithKline takes RSV maternal vaccine candidate into Phase 3 study

Submitted by admin on November 24, 2020 - 10:49am
Source: 
Biopharma Reporter
News Tags: 
GSK
vaccines
RSV
clinical trials
Headline: 
GlaxoSmithKline takes RSV maternal vaccine candidate into Phase 3 study
snippet: 

GlaxoSmithKline has started dosing patients in a Phase 3 clinical program investigating the safety and efficacy of its Respiratory Syncytial Virus (RSV) candidate vaccine for maternal immunisation.

Do Not Allow Advertisers to Use My Personal information